At 9.9% CAGR, Europe Microbiology CRO Services Market is Projected to be Worth US$ 3,304.54 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Europe microbiology CRO services market was valued at US$ 1,548.24 million in 2023 and is expected to reach US$ 3,304.54 million by 2031, registering a CAGR of 9.9% from 2023 to 2031. Surging research and development investments and advancements in microbiology testing technology are among the critical factors attributed to the Europe microbiology CRO services market expansion.

Research is a significant and essential part of the pharmaceutical, biopharmaceutical, and medical device industries, among others, which enables them to develop new solutions for various therapeutic applications with significant medical and commercial potential. The pharmaceutical industry is one of the most research and development-intensive industries in the world. Efforts are being made to achieve greater effectiveness and efficiency in fulfilling patients' needs. The cost of medicines has been a prime concern for pharmaceutical companies as they bank on their research and development activities to achieve intended cost targets. Over the last decade, the number of new drugs approved yearly has also increased.

Research and development expenditure is instrumental in companies' efforts to discover, examine, and produce new products; make upfront payments; improve existing outcomes; and demonstrate product efficacy and regulatory compliance before launch. These investments differ as per the need and demand for clinical trials. The cost includes materials, supplies used, and employee salaries, along with the cost of developing quality control. According to PhRMA Member Companies 2021 report, in terms of revenue, the top 15 largest pharmaceutical companies invested US$ 133 billion in research and development cumulatively, and ~44% of the total research and development investment was allocated to clinical trials. Pharmaceutical companies are investing heavily in research and development to create new antibiotics, vaccines, and treatments for infectious diseases. These developments require thorough testing and validation of microbial strains. Similarly, medical device companies are working on innovative products, such as implantable devices, wound care products, and surgical instruments, which also require rigorous testing to ensure sterility and prevent contamination. Microbial testing CROs offer specialized services, including bacterial identification, antimicrobial susceptibility testing, sterility testing, bioburden testing, and molecular testing, to support these research and development efforts. The increasing demand for personalized medicine, targeted therapies, and implantable devices is also increasing the need for microbial testing CROs to provide customized testing services. Thus, increasing research and development investments fuel the microbiology CRO market growth.

On the contrary, shortage of skilled professionals hampers the growth of Europe microbiology CRO services market.

Based on application, the Europe microbiology CRO services market is segmented into clinical, medical device, and others. The clinical segment held 50.2% share of the Europe microbiology CRO services market in 2023, amassing US$ 777.15 million. It is projected to garner US$ 1,733.54 million by 2031 to expand at 10.5% CAGR during 2023-2031.

Based on service type, the Europe microbiology CRO services market is segmented into assay development, custom viral stock production, microbial testing, and others. The microbial testing segment held 61.1% share of the Europe microbiology CRO services market in 2023, amassing US$ 945.51 million. It is projected to garner US$ 2,047.99 million by 2031 to expand at 10.1% CAGR during 2023-2031.

Based on microorganisms, the Europe microbiology CRO services market is segmented into bacteria, fungi, viruses, and parasites. The bacteria segment held 45.4% share of the Europe microbiology CRO services market in 2023, amassing US$ 702.14 million. It is projected to garner US$ 1,544.49 million by 2031 to expand at 10.4% CAGR during 2023-2031.

Based on end user, the Europe microbiology CRO services market is segmented into biotech and pharmaceutical companies, medical device companies, and others. The biotech and pharmaceutical companies segment held 57.9% share of the Europe microbiology CRO services market in 2023, amassing US$ 897.17 million. It is projected to garner US$ 1,961.63 million by 2031 to expand at 10.3% CAGR during 2023-2031.

Based on country, the Europe microbiology CRO services market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held 21.3% share of Europe microbiology CRO services market in 2023, amassing US$ 329.00 million. It is projected to garner US$ 743.75 million by 2031 to expand at 10.7% CAGR during 2023-2031.

Key players operating in the microbiology CRO services market are Microbiologics; Melbec Microbiology; Emery Pharma; TheraIndx Lifesciences Pvt. Ltd.; AVERIN BIOTECH; Statens Serum Institut; ImQuest BioSciences; PACIFIC BIOLABS; Innovotech Inc.; and BluTest Laboratories Ltd, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com